Hims & Hers Health, Inc. (HIMS) Tops Q4 EPS by 2c, Guidance Tops Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- UBS Reiterates Buy Rating on Snowflake Inc. (SNOW)
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
February 26, 2024 4:05 PM ESTRevenue of $872.0 million, up 65% year-over-year in 2023
Net income of $1.2 million; Adjusted EBITDA profitability of $20.6 million in Q4 2023
Subscribers grew to 1.5 million, up 48% year-over-year in Q4 2023
Provides Q1 and full year 2024 guidance, with full year 2024 revenue in the range of $1.17 billion to $1.20 billion and Adjusted EBITDA in the range of $100 million to $120 million
SAN FRANCISCO--(BUSINESS WIRE)-- Hims & Hers Health, Inc. (Hims & Hers or the Company) (NYSE: HIMS), the leading health and wellness platform, today announced... More
